Results 61 to 70 of about 137,565 (249)

The Influence of COVID‐19 on the Composition and Drug Resistance of Pleural Effusion in Shandong Province

open access: yesMicrobiologyOpen, Volume 15, Issue 2, April 2026.
Our results show that the COVID‐19 pandemic has a significant impact on the detection of pathogens and drug resistance in pleural effusion in Shandong Province. ABSTRACT To analyze the composition and drug resistance changes of pleural effusion in Shandong region from 2017 to 2024, and to provide a basis for clinical empirical treatment and future ...
Wenwen Yu   +60 more
wiley   +1 more source

Unusual presentation of pulmonary hydatidosis mimicking massive pleural effusion

open access: yesPAMJ Clinical Medicine, 2020
Massive pleural effusions are commonly caused by malignancy, parapneumonic effusion, and tuberculosis. Parasitic infections are rare causes of massive pleural effusion.
Hanane Haddaoui   +4 more
doaj   +1 more source

Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar [PDF]

open access: yes, 2011
To assess invasive pneumococcal disease (IPD) clinical presentations and relationships with age and serotype in hospitalized children (36 months (51.4% for 36 to 59 months and 40.0% for >59 months), while serotype 19A was linked to nonrespiratory IPDs (
Balboa, F.   +9 more
core   +2 more sources

Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre's 10 years of experience [PDF]

open access: yes, 2020
BACKGROUND: Recurrent pleural effusion is a common cause of dyspnoea, cough and chest pain during the course of infectious pleurisy and non-malignant diseases like congestive heart failure (CHF) or liver cirrhosis with hepatic hydrothorax (HH). With
Brünger, Martin   +6 more
core   +1 more source

Rheumatoid Arthritis–Associated Pleural Effusion in an Elderly Female With Multimorbidity: A Case Report and Diagnostic Challenge

open access: yesRespirology Case Reports, Volume 14, Issue 4, April 2026.
RA Pleural Effusion is a rare but clinically significant extra‐articular manifestation of RA, presenting diagnostic challenges in patients with multimorbidity. This case underscores the importance of considering autoimmune aetiologies in unexplained exudative pleural effusions, particularly when accompanied by joint symptoms or seropositivity.
Aatif Syed   +2 more
wiley   +1 more source

Video-assisted thoracoscpic muscle transposition for acute empyema. [PDF]

open access: yes, 2015
Muscle flap transposition is one of the surgical treatment options for empyema with alveolarpleural fistula (APF) or bronchopleural fistula (BPF). This surgical procedure is invasive because it is typically performed by standard thoracotomy. We performed
Kanzaki Masato   +3 more
core   +5 more sources

Once-daily intrapleural urokinase treatment of complicated parapneumonic effusion in pediatric patients [PDF]

open access: yes, 2010
In this paper, we describe our experience in the treatment of childhood empyema using urokinase. Patients' ages ranged from 2 to 12 years. Urokinase (dosage: 3,100 IU/kg/day) was diluted in normal saline to produce 1000 IU/ml (maximum dosage 100,000 IU ...
Bergamini, Barbara Maria   +6 more
core  

Lung abscess predicts the surgical outcome in patients with pleural empyema [PDF]

open access: yes, 2010
Objectives Most cases of pleural empyema are caused by pulmonary infections, which are usually combined with pneumonia or lung abscess. The mortality of patients with pleural empyema remains high (up to 20%).
Hung-Che Huang   +5 more
core   +1 more source

Bilateral parapneumonic pleural effusion with pneumothorax in a patient with covid 19 pneumonia: case report

open access: yesRadiology Case Reports, 2022
Recurrent pyogenic effusion combined with bilateral pneumothorax is a rare complication associated with the COVID−19 infection. Current article presents the case report of a 68-year-old male with the severe community-acquired bilateral polysegmental ...
T. Kalenchic   +4 more
semanticscholar   +1 more source

A Parallel Group, 1:1 Randomised, Pilot Study Comparing the Clinical Efficacy and Bleeding Risk Between Low Dose and Standard Dose Intrapleural Tissue Plasminogen Activator for Adults With Pleural Infection

open access: yesRespirology Case Reports, Volume 14, Issue 4, April 2026.
This protocol is for the TRAPPE study, a pilot study to serve as preparatory work before proceeding to a full‐scale, multicentre RCT. The feasibility of the study design involving flexibility of dose escalation and various clinical parameters will be tested for suitability as study outcome measurements before proceeding to a full‐scale RCT.
Ken Ka Pang Chan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy